In Volume 93, Issue 10, October 2015, throughout pages 674−83 “Rivaroxavan” should read: “Rivaroxaban”.
. 2016 May 2;94(5):404. doi: 10.2471/BLT.16.100516
Corrigendum
Issue date 2016 May 1.
(c) 2016 The authors; licensee World Health Organization.
This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
PMCID: PMC4850540 PMID: 27147774
This corrects the article "Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted" in volume 93 on page 674.
